Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Peppermint Venture Partners GmbH (PVP) is a private venture capital firm based in Berlin, Germany, founded in 2000. The firm emerged from Peppermint Holding, a mid-sized industrial group, and is dedicated to supporting entrepreneurs and scientists in the life sciences sector. PVP focuses on transforming healthcare through innovative solutions that enhance efficiency, accessibility, and cost containment.
Currently, PVP manages approximately €50 million in assets under management (AUM) and has established a portfolio of eight companies. The firm operates primarily in Europe, with a strong emphasis on the German-speaking region. PVP has made notable strides in the healthcare investment space, particularly through its partnership with Charite Medical School, one of Europe’s leading medical university hospitals, which provides unique access to deal flow and networks.
Peppermint Venture Partners primarily invests in early-stage life sciences companies, emphasizing disruptive innovations in medical devices, diagnostics, and digital health. The firm targets pre-seed, seed, seed-plus, and Series A stages, with a check size range that aligns with early-stage funding needs. PVP seeks to enhance the healthcare system's efficiency and accessibility through patent-protected technologies and innovative business models.
The firm’s investment thesis focuses on addressing unmet medical needs and improving healthcare efficiency. PVP looks for companies that offer innovative products or business models capable of transforming healthcare delivery. This includes a strong preference for technologies that can demonstrate potential for cost containment and improved patient outcomes.
Peppermint Venture Partners has made several notable investments in the life sciences sector. The firm’s portfolio includes:
These companies exemplify PVP’s commitment to investing in disruptive innovations that enhance healthcare delivery and patient outcomes.
Ingeborg Neumann - Managing Partner. Ingeborg co-founded PVP and has extensive experience in venture capital and the life sciences sector. She has been instrumental in shaping the firm’s investment strategy and portfolio development.
Dr. Joachim Rautter - Managing Partner. Dr. Rautter brings a wealth of knowledge in medical technology and has led several successful investments in the healthcare space.
Dr. Klaus Stöckemann - Managing Partner. Dr. Stöckemann has a strong background in biotechnology and has played a key role in identifying and supporting innovative startups within PVP’s portfolio.
To pitch Peppermint Venture Partners, founders should utilize the contact form available on their website at pvp.health. It is crucial to include a comprehensive pitch deck that outlines the business model, market opportunity, and team qualifications. PVP prefers detailed information on financial projections and growth strategies.
Response times may vary, but founders can expect to hear back within a few weeks. Warm introductions are beneficial, particularly through mutual connections in the healthcare or venture capital sectors.
In 2023, Peppermint Venture Partners announced the launch of its latest initiative, the LIIDO Fund, which aims to raise €100 million for investments in European life science tools and services. This fund will further enhance PVP's capacity to support innovative healthcare solutions.
Additionally, PVP continues to expand its portfolio, with recent investments in companies focused on medical devices and digital health solutions. The firm remains active in seeking out disruptive innovations that align with its investment thesis.
What are Peppermint Venture Partners' investment criteria?
PVP focuses on early-stage life sciences companies, particularly those with patent-protected technologies and innovative business models. The firm seeks to invest in companies that address unmet medical needs and improve healthcare efficiency.
How can startups apply or pitch to Peppermint Venture Partners?
Startups can pitch to PVP through their website at pvp.health. It is recommended to include a detailed business plan, financial projections, and information about the team in the pitch deck.
What makes Peppermint Venture Partners different from other VCs?
PVP has a unique partnership with Charite Medical School, providing access to a vast network and deal flow in the life sciences sector. This collaboration enhances the support and resources available to portfolio companies.
What is the geographic scope of Peppermint Venture Partners?
PVP primarily invests in early-stage companies across Europe, with a strong focus on the German-speaking region.
What is the typical fund size and check size for Peppermint Venture Partners?
PVP manages approximately €50 million in assets and typically invests in early-stage rounds, including pre-seed, seed, seed-plus, and Series A funding stages.
What kind of post-investment involvement does Peppermint Venture Partners have?
PVP actively supports its portfolio companies through strategic guidance, access to networks, and resources from its partnership with Charite Medical School.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.